PL374487A1 - Kompozycje farmaceutyczne o kontrolowanym uwalnianiu zawierające alginian sodowy i alginian sodowo-wapniowy - Google Patents
Kompozycje farmaceutyczne o kontrolowanym uwalnianiu zawierające alginian sodowy i alginian sodowo-wapniowyInfo
- Publication number
- PL374487A1 PL374487A1 PL03374487A PL37448703A PL374487A1 PL 374487 A1 PL374487 A1 PL 374487A1 PL 03374487 A PL03374487 A PL 03374487A PL 37448703 A PL37448703 A PL 37448703A PL 374487 A1 PL374487 A1 PL 374487A1
- Authority
- PL
- Poland
- Prior art keywords
- alginate
- sodium
- pharmaceutical compositions
- controlled release
- compositions containing
- Prior art date
Links
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 title 1
- VEUACKUBDLVUAC-UHFFFAOYSA-N [Na].[Ca] Chemical compound [Na].[Ca] VEUACKUBDLVUAC-UHFFFAOYSA-N 0.000 title 1
- 235000010410 calcium alginate Nutrition 0.000 title 1
- 239000000648 calcium alginate Substances 0.000 title 1
- 229960002681 calcium alginate Drugs 0.000 title 1
- 238000013270 controlled release Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 235000010413 sodium alginate Nutrition 0.000 title 1
- 239000000661 sodium alginate Substances 0.000 title 1
- 229940005550 sodium alginate Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SI200200242A SI21300A (sl) | 2002-10-08 | 2002-10-08 | Farmacevtske formulacije z alginati |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL374487A1 true PL374487A1 (pl) | 2005-10-31 |
| PL208591B1 PL208591B1 (pl) | 2011-05-31 |
Family
ID=32091983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL374487A PL208591B1 (pl) | 2002-10-08 | 2003-10-06 | Kompozycje farmaceutyczne o kontrolowanym uwalnianiu zawierające alginian sodowy i alginian sodowo-wapniowy |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1560568B1 (pl) |
| AU (1) | AU2003273212A1 (pl) |
| EA (1) | EA007488B1 (pl) |
| HR (1) | HRP20050312B1 (pl) |
| PL (1) | PL208591B1 (pl) |
| RS (1) | RS52818B (pl) |
| SI (2) | SI21300A (pl) |
| UA (1) | UA80990C2 (pl) |
| WO (1) | WO2004032904A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1799232B1 (en) | 2004-10-12 | 2015-10-07 | FMC Biopolymer AS | Self-gelling alginate systems and uses thereof |
| CN103463638A (zh) | 2007-08-28 | 2013-12-25 | Fmc有限公司 | 延迟的自胶凝藻酸盐体系及其应用 |
| CN108853039B (zh) * | 2018-08-07 | 2021-03-09 | 河北君临药业有限公司 | 一种克拉霉素分散片及其生产工艺 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3583799D1 (de) * | 1985-01-11 | 1991-09-19 | Abbott Lab Ltd | Feste zubereitung mit langsamer freisetzung. |
| EP0275336A1 (de) * | 1987-01-20 | 1988-07-27 | Knoll Ag | Arzneimittelzubereitung mit protahierender Wirkung |
| US5705190A (en) * | 1995-12-19 | 1998-01-06 | Abbott Laboratories | Controlled release formulation for poorly soluble basic drugs |
| SI20108B (en) * | 1997-06-11 | 2001-12-31 | Abbott Lab | A controlled release formulation for poorly soluble basic drugs |
-
2002
- 2002-10-08 SI SI200200242A patent/SI21300A/sl not_active IP Right Cessation
-
2003
- 2003-06-10 UA UAA200504316A patent/UA80990C2/uk unknown
- 2003-10-06 EA EA200500613A patent/EA007488B1/ru not_active IP Right Cessation
- 2003-10-06 RS YU20050276A patent/RS52818B/sr unknown
- 2003-10-06 SI SI200332359T patent/SI1560568T1/sl unknown
- 2003-10-06 EP EP03755718.8A patent/EP1560568B1/en not_active Expired - Lifetime
- 2003-10-06 AU AU2003273212A patent/AU2003273212A1/en not_active Abandoned
- 2003-10-06 PL PL374487A patent/PL208591B1/pl unknown
- 2003-10-06 WO PCT/SI2003/000034 patent/WO2004032904A1/en not_active Ceased
- 2003-10-06 HR HRP20050312AA patent/HRP20050312B1/hr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20050312B1 (hr) | 2014-09-26 |
| EP1560568A1 (en) | 2005-08-10 |
| HRP20050312A2 (en) | 2006-02-28 |
| EA007488B1 (ru) | 2006-10-27 |
| UA80990C2 (en) | 2007-11-26 |
| SI1560568T1 (sl) | 2014-08-29 |
| RS20050276A (sr) | 2007-06-04 |
| EA200500613A1 (ru) | 2005-10-27 |
| WO2004032904A1 (en) | 2004-04-22 |
| AU2003273212A1 (en) | 2004-05-04 |
| RS52818B (sr) | 2013-10-31 |
| EP1560568B1 (en) | 2014-03-26 |
| PL208591B1 (pl) | 2011-05-31 |
| SI21300A (sl) | 2004-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL160117A0 (en) | Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption | |
| HUP0400384A3 (en) | Benzamidine derivative and pharmaceutical compositions containing them and their use | |
| IL164987A0 (en) | Proline derivatives and pharmaceutical compositions containing | |
| HUP0303325A3 (en) | Pharmaceutical salts and pharmaceutical compositions containing them | |
| HUS1400025I1 (hu) | Feniletanolamin-származékok és az ezeket tartalmazó gyógyszerek | |
| IL164376A0 (en) | Ox4or binding agents, their preparation and pharmaceutical compositions containing them | |
| EP1424994A4 (en) | PREPARATION OF A SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION | |
| AU2003291103A8 (en) | Pharmaceutical composition | |
| HUP0401333A3 (en) | Spiropyrazole compounds and pharmaceutical compositions containing them | |
| EG24479A (en) | Modified release pharmaceutical formulation | |
| IL164547A0 (en) | Pharmaceutical composition | |
| SI1458377T1 (sl) | Tegaserodovi farmacevtski sestavki | |
| AU2003222921A8 (en) | Novel perindopril salt and pharmaceutical compositions containing same | |
| AU2003260803A8 (en) | Sustained release pharmaceutical composition | |
| AU2003250372A8 (en) | Pharmaceutical composition | |
| IL165069A0 (en) | Immediate release pharmaceutical formulation | |
| EP1404301A4 (en) | PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE, STABLE, CONTAINING PRAVASTATIN | |
| IL176077A0 (en) | 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them | |
| SI1560568T1 (sl) | Farmacevtski sestavki z nadzorovanim sproščanjem, ki vsebujejo natrijev alginat in natrijev-kalcijev alginat | |
| GB2406517B (en) | Minocycline controlled release pharmaceutical composition | |
| AU2003258772A8 (en) | Novel neutracetical and pharmaceutical compositions and their uses | |
| AU2002236132A1 (en) | Modified release oral pharmaceutical composition | |
| GB0217703D0 (en) | Pharmaceutical composition | |
| EP1547593A4 (en) | MEDICINAL COMPOSITION | |
| AU2003300986A1 (en) | An extended release pharmaceutical composition of phenytoin sodium |